Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer von SHAH, Chirayu, MILLER, Todd W, BALDWIN, Ronald M, GORE, John C, SCHIFF, Rachel, ARTEAGA, Carlos L, MANNING, H. Charles, WYATT, Shelby K, MCKINLEY, EliotT, GRACIELA OLIVARES, Maria, SANCHEZ, Violeta, NOLTING, Donald D, BUCK, Jason R, PING ZHAO, SIB ANSARI, M

Volltext